Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;7(8):663-664.
doi: 10.1016/S2215-0366(20)30291-1.

Psychiatric and neuropsychiatric syndromes and COVID-19

Affiliations
Comment

Psychiatric and neuropsychiatric syndromes and COVID-19

Latha Velayudhan et al. Lancet Psychiatry. 2020 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Rogers JP, Chesney E, Oliver D. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 doi: 10.1016/S2215-0366(20)30203-0. published online May 18. - DOI - PMC - PubMed
    1. Fong TG, Davis D, Growdon ME, Albuquerque A, Inouye SK. The interface between delirium and dementia in elderly adults. Lancet Neurol. 2015;14:823–832. - PMC - PubMed
    1. Li YC, Bai WZ, Hashikawa T. Response to commentary on “The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients”. J Med Virol. 2020 doi: 10.1002/jmv.25824. published online April 4. - DOI - PMC - PubMed
    1. Vik-Mo AO, Giil LM, Borda MG, Ballard C, Aarsland D. The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study. Br J Psychiatry. 2020;216:43–48. - PubMed
    1. Ballard C, Orrell M, YongZhong S. Impact of antipsychotic review and nonpharmacological intervention on antipsychotic use, neuropsychiatric symptoms, and mortality in people with dementia living in nursing homes: a factorial cluster-randomized controlled trial by the Well-Being and Health for People With Dementia (WHELD) program. Am J Psychiatry. 2016;173:252–262. - PubMed